Refresh

Farmax India Ltd. - Research Center

590094 FARMAXIND Group (T) BSE data
Back to Company

Results

Statement

More

Balance Sheet
(Rs crore)
Mar ' 17 Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13
Sources of funds
Owner's fund

Equity share capital

53.42 53.42 53.42 40.83 40.83

Share application money

- - - - -

Preference share capital

- - - - -

Reserves & surplus

-72.18 -69.42 -59.64 -61.56 -52.72
Loan funds

Secured loans

41.00 41.00 41.02 34.78 29.67

Unsecured loans

- - - - -

Total

22.24 25.00 34.81 14.05 17.78
Uses of funds
Fixed assets

Gross block

36.38 36.38 37.29 37.10 37.10

Less : revaluation reserve

7.03 7.03 7.03 7.03 7.03

Less : accumulated depreciation

19.32 18.01 17.22 15.05 13.11

Net block

10.02 11.34 13.04 15.02 16.95

Capital work-in-progress

- - - - -

Investments

- - - - -
Net current assets

Current assets, loans & advances

13.62 15.49 24.67 8.90 8.51

Less : current liabilities & provisions

1.41 1.83 2.91 9.87 7.68

Total net current assets

12.21 13.66 21.76 -0.97 0.83

Miscellaneous expenses not written

- - - - -

Total

22.24 25.00 34.81 14.05 17.78
Notes:

Book value of unquoted investments

- - - - -

Market value of quoted investments

- - - - -

Contingent liabilities

- - 2.36 5.35 5.24

Number of equity sharesoutstanding (Lacs)

5341.71 5341.71 5341.71 4083.00 4083.00
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com